Gastrointestinal Stents Market Forecasts to 2030 – Global Analysis By Product (Duodenal Stent, Biliary Stent, Pancreatic Stent, Colonic Stent and Esophageal Stent), Type (Anti-Migratory Stents, Radioactive Stents, Drug-Eluting Stents, Anti-Reflux Stents,

Gastrointestinal Stents Market Forecasts to 2030 – Global Analysis By Product (Duodenal Stent, Biliary Stent, Pancreatic Stent, Colonic Stent and Esophageal Stent), Type (Anti-Migratory Stents, Radioactive Stents, Drug-Eluting Stents, Anti-Reflux Stents, Shape-Modified Stents and Other Types), Material, Application, End User and By Geography


According to Stratistics MRC, the Global Gastrointestinal Stents Market is accounted for $529.71 million in 2023 and is expected to reach $884.56 million by 2030 growing at a CAGR of 7.6% during the forecast period. Gastrointestinal stents are medical devices used to treat narrowed or blocked passages within the digestive system, such as the esophagus, stomach, or intestines. These tubular structures are inserted endoscopically to provide support, relieve obstruction, and facilitate the flow of fluids or food. Gastrointestinal stents play a crucial role in managing conditions like strictures, tumours, or obstructions, offering a minimally invasive alternative to surgery.

According to published report of 2022 in current oncology research article of MDPI publisher, reported upper gastrointestinal cancer incidences in China were 14,934,040 cases of male and 6,262,431 cases of female with growth rate 181.44% in between 1990 to 2019.

Market Dynamics:

Driver:

Increasing prevalence of gastrointestinal disorders

The escalating prevalence of gastrointestinal disorders, such as colorectal cancer, inflammatory bowel disease, and gastrointestinal strictures necessitates effective therapeutic interventions, where gastrointestinal stents play a crucial role in providing relief and improving patient outcomes. These stents facilitate the restoration of normal digestive function, alleviate symptoms, and offer minimally invasive solutions. The growing awareness of these disorders, coupled with advancements in stent technologies, further propels market growth as healthcare professionals increasingly opt for these devices to address the surging demand for gastrointestinal interventions.

Restraint:

Lack of awareness

Lack of awareness about gastrointestinal issues and available treatment options may lead to delayed diagnosis and treatment. It can hinder patient education and shared decision-making between healthcare providers and patients, limiting the choices available for managing gastrointestinal conditions. From a market perspective, manufacturers and suppliers may face challenges in promoting their products and expanding their market share if there is insufficient awareness among both healthcare professionals and the general public.

Opportunity:

Rising customized & patient-specific solutions

Tailoring gastrointestinal stents to individual patient needs enhances treatment efficacy and minimizes potential complications. This trend not only addresses unique anatomical variations but also improves overall patient outcomes, driving innovation and growth within the market. As demand for personalized medical interventions continues to rise, the integration of customized solutions in the gastrointestinal stents sector positions itself as a key avenue for advancement and market expansion.

Threat:

Availability of alternative treatment options

Patients and healthcare providers may opt for non-stent interventions, such as medications or minimally invasive procedures, reducing the demand for gastrointestinal stents. This shift in preferences could impact the market share and revenue potential for traditional stent manufacturers, emphasizing the need for innovation, improved efficacy, and strategic differentiation to maintain a competitive edge in the evolving landscape of gastrointestinal treatments.

Covid-19 Impact

The covid-19 pandemic has impacted the Gastrointestinal Stents Market by causing disruptions in the supply chain, delaying elective procedures, and diverting healthcare resources to manage the crisis. These factors have led to a temporary decline in the demand for gastrointestinal stents. However, as healthcare systems adapt to the new normal and elective procedures resume, the market has recovered. The increased focus on endoscopic procedures and advancements in stent technology also drive future growth in the gastrointestinal stents market.

The self-expanding metal stents segment is expected to be the largest during the forecast period

The self-expanding metal stents segment is estimated to have a lucrative growth. Self-expanding metal stents (SEMS) play a pivotal role in Gastrointestinal Stents, offering a minimally invasive solution for various conditions. Composed of metal alloys, these stents automatically expand upon deployment, providing structural support to obstructed or narrowed gastrointestinal passages. SEMS effectively alleviate symptoms, such as blockages or strictures, enabling improved digestive function. Their versatility and adaptability make them a preferred choice for treating conditions like esophageal, colorectal, and biliary obstructions.

The gastrointestinal cancers segment is expected to have the highest CAGR during the forecast period

The gastrointestinal cancers segment is anticipated to witness the highest CAGR growth during the forecast period. Gastrointestinal stents play a crucial role in managing gastrointestinal cancers by alleviating symptoms and improving the quality of life for patients. Deployed through endoscopic procedures, these stents provide a minimally invasive solution, restoring proper functioning and enabling the passage of food and fluids. Gastrointestinal stents serve as palliative care, enhancing patient comfort and facilitating treatment plans.

Region with largest share:

Asia Pacific is projected to hold the largest market share during the forecast period owing to the rising gastrointestinal disorders and an aging population. Countries like China, Japan, and India are prominent contributors to the market's growth. It is home for major key players such as Boston, Medtronic and Abbott Laboratories. The demand for minimally invasive procedures and a growing prevalence of diseases such as colorectal cancer are fueling the adoption of gastrointestinal stents in the region. The market is poised for continued expansion as healthcare infrastructure improves and the need for effective gastrointestinal interventions rises.

Region with highest CAGR:

North America is projected to have the highest CAGR over the forecast period, owing to the increasing prevalence of obstructive gastrointestinal diseases, favourable reimbursement policies and aging population. North America is one of the most developed medical device industries market. Further, the booming medical tourism industry in the region owing to availability of the advanced medical treatments at a cheaper cost is anticipated to expand the patient base in the region.

Key players in the market

Some of the key players profiled in the Gastrointestinal Stents Market include Boston Scientific Corporation, Hobbs Medical Inc., General Electric Company, Cantel Medical Corporation, Olympus Corporation, Merit Medical Systems, Qualimed, Medtronic, Conmed Corporation, Terumo Corporation, Johnson & Johnson, The 3M Company, Smith & Nephew, Diagmed Healthcare, Medline Industries, Baxter, B. Braun Melsungen AG and Danaher Corporation.

Key Developments:

In November 2020, Boston Scientific Corporation (US) has received 510(k) approval from the U.S. Food and Drug Administration (FDA) and CE Mark approval to market its WallFlex Fully Covered Esophageal Stent for the treatment of malignant esophageal strictures caused by esophageal cancer.

In October 2020, Olympus Corporation (Japan) launched HANAROSTENT Esophagus TTS Self-expanding Metal Stents (SEMS) made by MI-Tech and distributed exclusively through Olympus in the US.

Products Covered:
• Duodenal Stent
• Biliary Stent
• Pancreatic Stent
• Colonic Stent
• Esophageal Stent

Types Covered:
• Anti-Migratory Stents
• Radioactive Stents
• Drug-Eluting Stents
• Anti-Reflux Stents
• Shape-Modified Stents
• Other Types

Materials Covered:
• Self–Expanding Metal Stents
• Plastic Stents
• Other Materials

Applications Covered:
• Stomach Cancer
• Irritable Bowel Syndrome
• Pancreatic Cancer
• Colorectal Cancer
• Gastrointestinal Cancers
• Esophageal Cancer
• Biliary Diseases
• Other Applications

End Users Covered:
• Ambulatory Surgical Centers
• Hospitals
• Specialty Clinics

Regions Covered:
• North America
US
Canada
Mexico
• Europe
Germany
UK
Italy
France
Spain
Rest of Europe
• Asia Pacific
Japan
China
India
Australia
New Zealand
South Korea
Rest of Asia Pacific
• South America
Argentina
Brazil
Chile
Rest of South America
• Middle East & Africa
Saudi Arabia
UAE
Qatar
South Africa
Rest of Middle East & Africa

What our report offers:

- Market share assessments for the regional and country-level segments

- Strategic recommendations for the new entrants

- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030

- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)

- Strategic recommendations in key business segments based on the market estimations

- Competitive landscaping mapping the key common trends

- Company profiling with detailed strategies, financials, and recent developments

- Supply chain trends mapping the latest technological advancements


1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Application Analysis
3.8 End User Analysis
3.9 Emerging Markets
3.10 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Gastrointestinal Stents Market, By Product
5.1 Introduction
5.2 Duodenal Stent
5.3 Biliary Stent
5.4 Pancreatic Stent
5.5 Colonic Stent
5.6 Esophageal Stent
6 Global Gastrointestinal Stents Market, By Type
6.1 Introduction
6.2 Anti-Migratory Stents
6.3 Radioactive Stents
6.4 Drug-Eluting Stents
6.5 Anti-Reflux Stents
6.6 Shape-Modified Stents
6.7 Other Types
7 Global Gastrointestinal Stents Market, By Material
7.1 Introduction
7.2 Self–Expanding Metal Stents
7.3 Plastic Stents
7.4 Other Materials
8 Global Gastrointestinal Stents Market, By Application
8.1 Introduction
8.2 Stomach Cancer
8.3 Irritable Bowel Syndrome
8.4 Pancreatic Cancer
8.5 Colorectal Cancer
8.6 Gastrointestinal Cancers
8.7 Esophageal Cancer
8.8 Biliary Diseases
8.9 Other Applications
9 Global Gastrointestinal Stents Market, By End User
9.1 Introduction
9.2 Ambulatory Surgical Centers
9.3 Hospitals
9.4 Specialty Clinics
10 Global Gastrointestinal Stents Market, By Geography
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 New Zealand
10.4.6 South Korea
10.4.7 Rest of Asia Pacific
10.5 South America
10.5.1 Argentina
10.5.2 Brazil
10.5.3 Chile
10.5.4 Rest of South America
10.6 Middle East & Africa
10.6.1 Saudi Arabia
10.6.2 UAE
10.6.3 Qatar
10.6.4 South Africa
10.6.5 Rest of Middle East & Africa
11 Key Developments
11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies
12 Company Profiling
12.1 Boston Scientific Corporation
12.2 Hobbs Medical Inc.
12.3 General Electric Company
12.4 Cantel Medical Corporation
12.5 Olympus Corporation
12.6 Merit Medical Systems
12.7 Qualimed
12.8 Medtronic
12.9 Conmed Corporation
12.10 Terumo Corporation
12.11 Johnson & Johnson
12.12 The 3M Company
12.13 Smith & Nephew
12.14 Diagmed Healthcare
12.15 Medline Industries
12.16 Baxter
12.17 B. Braun Melsungen AG
12.18 Danaher Corporation
List of Tables
Table 1 Global Gastrointestinal Stents Market Outlook, By Region (2021-2030) ($MN)
Table 2 Global Gastrointestinal Stents Market Outlook, By Product (2021-2030) ($MN)
Table 3 Global Gastrointestinal Stents Market Outlook, By Duodenal Stent (2021-2030) ($MN)
Table 4 Global Gastrointestinal Stents Market Outlook, By Biliary Stent (2021-2030) ($MN)
Table 5 Global Gastrointestinal Stents Market Outlook, By Pancreatic Stent (2021-2030) ($MN)
Table 6 Global Gastrointestinal Stents Market Outlook, By Colonic Stent (2021-2030) ($MN)
Table 7 Global Gastrointestinal Stents Market Outlook, By Esophageal Stent (2021-2030) ($MN)
Table 8 Global Gastrointestinal Stents Market Outlook, By Type (2021-2030) ($MN)
Table 9 Global Gastrointestinal Stents Market Outlook, By Anti-Migratory Stents (2021-2030) ($MN)
Table 10 Global Gastrointestinal Stents Market Outlook, By Radioactive Stents (2021-2030) ($MN)
Table 10 Global Gastrointestinal Stents Market Outlook, By Drug-Eluting Stents (2021-2030) ($MN)
Table 12 Global Gastrointestinal Stents Market Outlook, By Anti-Reflux Stents (2021-2030) ($MN)
Table 13 Global Gastrointestinal Stents Market Outlook, By Shape-Modified Stents (2021-2030) ($MN)
Table 14 Global Gastrointestinal Stents Market Outlook, By Other Types (2021-2030) ($MN)
Table 15 Global Gastrointestinal Stents Market Outlook, By Material (2021-2030) ($MN)
Table 16 Global Gastrointestinal Stents Market Outlook, By Self–Expanding Metal Stents (2021-2030) ($MN)
Table 17 Global Gastrointestinal Stents Market Outlook, By Plastic Stents (2021-2030) ($MN)
Table 18 Global Gastrointestinal Stents Market Outlook, By Other Materials (2021-2030) ($MN)
Table 19 Global Gastrointestinal Stents Market Outlook, By Application (2021-2030) ($MN)
Table 20 Global Gastrointestinal Stents Market Outlook, By Stomach Cancer (2021-2030) ($MN)
Table 21 Global Gastrointestinal Stents Market Outlook, By Irritable Bowel Syndrome (2021-2030) ($MN)
Table 22 Global Gastrointestinal Stents Market Outlook, By Pancreatic Cancer (2021-2030) ($MN)
Table 23 Global Gastrointestinal Stents Market Outlook, By Colorectal Cancer (2021-2030) ($MN)
Table 24 Global Gastrointestinal Stents Market Outlook, By Gastrointestinal Cancers (2021-2030) ($MN)
Table 25 Global Gastrointestinal Stents Market Outlook, By Esophageal Cancer (2021-2030) ($MN)
Table 26 Global Gastrointestinal Stents Market Outlook, By Biliary Diseases (2021-2030) ($MN)
Table 27 Global Gastrointestinal Stents Market Outlook, By Other Applications (2021-2030) ($MN)
Table 28 Global Gastrointestinal Stents Market Outlook, By End User (2021-2030) ($MN)
Table 29 Global Gastrointestinal Stents Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
Table 30 Global Gastrointestinal Stents Market Outlook, By Hospitals (2021-2030) ($MN)
Table 31 Global Gastrointestinal Stents Market Outlook, By Specialty Clinics (2021-2030) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings